2Torbenson M, Thomas DL, Occult hepatitis B. Lancet Infect Dis, 2002,2 : 479-486.
3Kao JH, Chen PJ, Lai MY, et al. Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol, 2002,40 : 4068-4071.
4Jeantet D, Chemin I, Mandrand B, et al. Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient. Hepatology,2002,35 : 1215-1224.
5Aoki M, Saito T, Watanabe H, et al. Clinical significance of a highly sensitive enzyme immunoassay of hepatitis B surface antigen using a novel electron spin resonance technique. J Med Virol,2002,66 : 166-170.
6Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat, 2002,9:243-257.
7Kao JH, Chen PJ, Lai MY, et al. Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection. J Med Virol, 2002,68 : 216-220.
8Zanella I, Rossini A, Domenighini D, et al. Quantitive analysis of hepatitis B virus DNA by real-lime amplification. Eur J Clin Microbiol Infect Dis, 2002,21 : 22-26.
9Jardi R, Rodriguez F, Buti M, et al. Quantitative detection of hepatitis B virus DNA in serum by a new rapid real-time fluorescence PCR assay. J Viral Hepat, 2001,8 : 465-471.
10Chan HL, Tsang SW, Leung NW, et al. Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection. Am J Gastroenterol,2002,97 : 1211-1215.
3Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
6FERNANDEZ VILLAR A ,SOPENA B, VAZQUEZ R, et al.soniazidhepatotoxicity am ong drug users:the role of hepatitis C[J]. Clin Infect Dis, 2003,36: 293-- 298.
7DIENSTAG J L, SCHIFF E R,WRIGHT T L, et al. Lamivudine asinitial treatment for chronic hepatitis B in the United States[J]. N Engl J Med, 1999, 341: 1256--1263.
8MOMMEJA MARIN H, MONDOU E, BLUM M R, et al. Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature[J]. Hepatology, 2003,37:1309-- 1319.
